Shahin Lockman

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana.

Moraka NO, Choga WT, Pema MN, Chawawa MK, Gobe I, Mokomane M, Bareng OT, Bhebhe L, Kelentse N, Mulenga G, Pretorius Holme M, Mohammed T, Koofhethile CK, Makhema JM, Shapiro R, Lockman S, Moyo S, Gaseitsiwe S.

Sci Rep. 2023 10 24. 13(1):18134. PMID: 37875518

Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana.

Mosepele M, Bennett K, Gaolathe T, Makhema JM, Mmalane M, Holme MP, Lebelonyane R, Ometoruwa O, Mills LA, Powis KM, Leidner J, Jarvis JN, Tapela NM, Masupe T, Mokgatlhe L, Triant VA, Wirth KE, Moshomo T, Lockman S.

Sci Rep. 2023 10 19. 13(1):17814. PMID: 37857692

No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants.

Ajibola G, Mdluli C, Bennett K, Sakoi M, Batlang O, Makhema J, Lockman S, Shapiro R, Myer L, Powis K.

South Afr J HIV Med. 2023. 24(1):1509. PMID: 37928500

Hepatitis B surface antigen loss in chronic hepatitis B virus and HIV-1 Co-Infections individuals in Botswana.

Mpebe GGA, Phinius BB, Mutenga S, Baruti K, Bhebhe L, Choga WT, Jongman M, Pretorius-Holme M, Gaolathe T, Mmalane M, Shapiro R, Makhema J, Lockman S, Moyo S, Anderson M, Gaseitsiwe S.

AIDS. 2023 Oct 16. PMID: 37861688

Fostemsavir resistance-associated polymorphisms in HIV-1 subtype C in a large cohort of treatment-naïve and treatment-experienced individuals in Botswana.

Zuze BJL, Radibe BT, Choga WT, Bareng OT, Moraka NO, Maruapula D, Seru K, Mokgethi P, Mokaleng B, Ndlovu N, Kelentse N, Pretorius-Holme M, Shapiro R, Lockman S, Makhema J, Novitsky V, Seatla KK, Moyo S, Gaseitsiwe S.

Microbiol Spectr. 2023 Oct 12. e0125123. PMID: 37823653

Incidence and Predictors of Pregnancy in Women Enrolled in Large Multi-National HIV Treatment Trials of the AIDS Clinical Trials Group.

Omoz-Oarhe AE, Hughes MD, Bao Y, Short WR, Mngqibisa R, Cohn SE, Weinberg A, Rosa A, Collier A, Samaneka W, Morroni C, Lockman S.

J Acquir Immune Defic Syndr. 2023 Oct 09. PMID: 37820116

Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use.

Maruapula D, Moraka NO, Bareng OT, Mokgethi PT, Choga WT, Seatla KK, Kelentse N, Koofhethille CK, Zuze BJL, Gaolathe T, Pretorius-Holme M, Makhema J, Novitsky V, Shapiro R, Moyo S, Lockman S, Gaseitsiwe S.

J Antimicrob Chemother. 2023 10 03. 78(10):2489-2495. PMID: 37585352

The impact of free antiretroviral therapy for pregnant non-citizens and their infants in Botswana.

Fennell C, Escudero D, Zash R, Diseko M, Mayondi G, Mabuta J, Sekoto T, Gaolathe T, Mmalane M, Lockman S, Makhema J, Shapiro R.

J Int AIDS Soc. 2023 10. 26(10):e26161. PMID: 37885157

Lower academic performance among children with perinatal HIV exposure in Botswana.

Powis KM, Lebanna L, Schenkel S, Masasa G, Kgole SW, Ngwaca M, Kgathi C, Williams PL, Slogrove AL, Shapiro RL, Lockman S, Mmalane MO, Makhema JM, Jao J, Cassidy AR.

J Int AIDS Soc. 2023 Oct. 26 Suppl 4:e26165. PMID: 37909233

Pathways and Intersections: Multifaceted Approaches to Engage Individuals From Underrepresented and Marginalized Communities in HIV Research and Career Development.

Irie WC, Chitneni P, Glynn TR, Allen W, Chai PR, Engelman AN, Hurtado R, Li JZ, Li P, Lockman S, Marcus JL, Ogunshola FJ, Rönn MM, Haberer J, Ghebremichael M, Ciaranello A.

J Acquir Immune Defic Syndr. 2023 10 01. 94(2S):S116-S121. PMID: 37707858